Delivery Order SPE2DB20D7059-SPE2DB24FQFQ7
- Not listed
- This federal contract award is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S pharmaceutical products to the Defense Logistics Agency (DLA). The $1,019.04 firm fixed-price delivery order was issued to Amerisourcebergen Drug Corp, a major supplier of pharmaceuticals and medical supplies to the U.S. government, through its Corporate Office division. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
- This federal contract award is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S medical patches, with a ceiling value of $2,439.52. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a primary...
- This federal contract award is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The $1,371.22 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on May 11, 2023, with a completion date of May 12, 2023. The award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
- The federal contract award is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S pharmaceutical products to the Defense Logistics Agency (DLA). The $1,796.62 firm fixed-price delivery order was awarded to the Corporate Office division of Amerisourcebergen Drug Corp, a major pharmaceutical distributor. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. Under...
- This federal contract award is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,258.32 and is a firm fixed-price delivery order. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract is not set aside and was awarded on June 26, 2025, with a completion date of June 27,...
- This federal contract award is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S pharmaceutical products to the Defense Logistics Agency (DLA). The $1,389.84 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is associated with Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award is for the delivery of the pharmaceutical product XULANE 150-35 MCG/DAY PATCH 3S to the U.S. government. The contract, valued at $3,735.87, was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to federal agencies, particularly the Department of Defense (DoD) and Veterans Affairs (VA). The contract is a delivery order issued under Amerisourcebergen's Indefinite Delivery Contract (IDC)...
- This federal contract award is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, in the amount of $4,748.16 on a firm fixed-price basis. The award does not have a set-aside designation, indicating open competition. The contract is a delivery order with an ultimate completion date of July...
- This federal contract award is for the delivery of the pharmaceutical product XULANE 150-35 MCG/DAY PATCH 3S to the Defense Logistics Agency (DLA). The contract, valued at $1,059.88, was awarded to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The award is a delivery order contract with a firm fixed price, and the ultimate completion date is June 21, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite...
- This federal contract award is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for a ceiling value of $1,933.12. The contract is a delivery order with a firm fixed-price pricing type and has an ultimate completion date of November 7, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that...
- SPE2DB20D7059Indefinite Delivery Contract
- SPE2DB20D7059-SPE2DB24FQFQ7Delivery Order
This federal contract award is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S pharmaceutical products to the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD). The award, valued at $2,375.10, was made to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the DoD worldwide. The contract does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 5/16/24 |